Jiawei Li
Auckland University of Technology, New Zealand
Biography
Jiawei (Stacey) Li obtained her MD in Clinical Medicine in 2016 and a Master’s Degree in 2018 from Jilin University, one of the key universities in China under the Chinese Government’s Building World-class University schemes of the “Project 985” and "Project 211". She is now a PhD candidate at the AUT under the supervision of A/Prof Dong-Xu Liu. Her research project is to delineate the mechanism of the SHON breast cancer biomarker using the CRISPR-Cas9 gene editing technique.